Beta Bionics Inc.

NASDAQ: BBNX · Real-Time Price · USD
16.70
1.60 (10.60%)
At close: Aug 14, 2025, 3:59 PM
16.38
-1.92%
After-hours: Aug 14, 2025, 07:58 PM EDT

Beta Bionics Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
Revenue
65.12M 11.99M 179K
Cost of Revenue
29.24M 5.69M n/a
Gross Profit
35.89M 6.31M 179K
Operating Income
-45.25M -35.85M -65.84M
Interest Income
3.91M n/a 196K
Pretax Income
-54.76M -44.1M -64.75M
Net Income
-54.76M -44.1M -64.75M
Selling & General & Admin
54.95M 24.21M 33.49M
Research & Development
26.18M 17.94M 31.43M
Other Expenses
n/a n/a 1.1M
Operating Expenses
81.14M 42.16M 66.02M
Interest Expense
n/a n/a 14K
Selling & Marketing Expenses
37.09M 11.99M 8.83M
Cost & Expenses
110.38M 47.84M 66.02M
Income Tax Expense
n/a n/a n/a
Shares Outstanding (Basic)
6.37M 5.3M 5M
Shares Outstanding (Diluted)
6.37M 5.3M 5M
EPS (Basic)
-8.6 -8.31 -12.96
EPS (Diluted)
-8.6 -8.31 -12.96
EBITDA
-44.1M -34.62M -63.4M
EBIT
-45.25M -35.85M -64.74M
Depreciation & Amortization
1.15M 1.23M 1.34M